Immunotherapy code Q2043 does not concern pulmonologists, and should remain an oncology issue. The latest Correct Coding Initiative (CCI) edits bundle chest radiologic guidance with several procedures on the lungs and pleura, and although CCI edits 17.3 group immunotherapy code Q2043 with a number of ventilation and gas procedures, you shouldn't worry -- here's why. Note: Prove Chest X-ray Distinctness From Thoracentesis To Override Bundle For the latest CCI edits version, you should keep an eye on bundled chest x-rays and chest tube procedures. In particular, both 71010 (Radiologic examination, chest; single view, frontal) and 71020 (Radiologic examination, chest, 2 views, frontal and lateral) become components of: CCI edits cite the reason for the bundle as "misuse of column two code with column one code." These edits have a modifier indicator of "1", so you may override the edits with a modifier (i.e., modifier 59, Distinct procedural service) on the column 2 code when the services are distinct. Example: Take note: The same guidelines apply for 32550-32551. In other words, you should consider code 75989 (Radiological guidance [i.e., fluoroscopy, ultrasound, or computed tomography], for percutaneous drainage [e.g., abscess, specimen collection], with placement of catheter, radiological supervision and interpretation) to represent radiologic guidance for catheter placement/confirmation, adds Pohlig. She also warns that "you should use 71010 and 71020 only for radiologic examination of the chest, and not to assist or confirm needle placement." Relax On Q2043 Bundle With Ventilation, Gas Procedures Meanwhile, the Provenge code Q2043 (Sipuleucel-T, minimum of 50 million autologous CD54+ cells activated with PAP-GM-CSF, including leukapheresis and all other preparatory procedures, per infusion) takes in the following ventilation and expired gas procedures as components: As much as the Column 2 codes classify as pulmonology procedures, the grouping with Q2043 does not affect pulmonologists since it involves testing/monitoring being bundled into Provenge administration -- a treatment used for prostate cancer, explains Pohlig.